Endogenous epinephrine protects against obesity induced insulin resistance

Autonomic Neuroscience: Basic and Clinical

Volumn 162, Issue 1-2, 2011, Pages 32-34

  Ziegler, Michael G ^a   Milic, Milos ^a   Sun, Ping ^a   Tang, Chih Min ^a   Elayan, Hamzeh ^b   Bao, Xuping ^a   Cheung, Wai Wilson ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Diabetes mellitus; Glucose; Mouse; Phenylethanolamine N methyltransferase; PNMT

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIETARY FATS; EATING; EPINEPHRINE; FEMALE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; SEX CHARACTERISTICS; WEIGHT GAIN;

EID: 79957977018     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2011.01.009     Document Type: Article

References (18)

1. Bao X., Lu C.M., Liu F., Gu Y., Dalton N.D., Zhu B.Q., Foster E., Chen J., Karliner J.S., Ross J., Simpson P.C., Ziegler M.G. Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation 2007, 116(9):1024-1031.
2. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84(1):277-359.
3. Castle A., Yaspelkis B.B., Kuo C.H., Ivy J.L. Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. Life Sci. 2001, 69(5):599-611.
4. Cryer P.E. Adrenaline: a physiological metabolic regulatory hormone in humans?. Int. J. Obes. Relat. Metab. Disord. 1993, 17(Suppl 3):S43-S46. discussion S68.
5. Cryer P.E., Davis S.N., Shamoon H. Hypoglycemia in diabetes. Diab. Care 2003, 26(6):1902-1912.
6. Davis N., Forges B., Wylie-Rosett J. Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes. Minerva Med. 2009, 100(3):221-228.
7. Jacob S., Rett K., Wicklmayr M., Agrawal B., Augustin H.J., Dietze G.J. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J. Hypertens. 1996, 14(4):489-494.
8. Jensen J., Ruzzin J., Jebens E., Brennesvik E.O., Knardahl S. Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation. Acta Physiol. Scand. 2005, 184(2):121-130.
9. Kennedy B., Ziegler M.G. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci. 1990, 47(23):2143-2153.
10. Kennedy B., Bigby T.D., Ziegler M.G. Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J. Clin. Invest. 1995, 95(6):2896-2902.
11. Kveiborg B., Christiansen B., Major-Petersen A., Torp-Pedersen C. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. Am. J. Cardiovasc. Drugs 2006, 6(4):209-217.
12. Navegantes L.C., Migliorini R.H., do Carmo Kettelhut I. Adrenergic control of protein metabolism in skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5(3):281-286.
13. Petro A.E., Cotter J., Cooper D.A., Peters J.C., Surwit S.J., Surwit R.S. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 2004, 53(4):454-457.
14. Petrou M., Wynne D.G., Boheler K.R., Yacoub M.H. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 1995, 92(Suppl. 9):II483-II489.
15. Seals D.R., Esler M.D. Human ageing and the sympathoadrenal system. J. Physiol. 2000, 528(Pt 3):407-417.
16. Sharma A.M., Pischon T., Hardt S., Kunz I., Luft F.C. Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension 2001, 37(2):250-254.
17. Sternbauer K., Luthman J., Hanni A., Jacobsson S.O. Clenbuterol-induced insulin resistance in calves measured by hyperinsulinemic, euglycemic clamp technique. Acta Vet. Scand. 1998, 39(2):281-289.
18. Westfall T.C., Westfal D.P. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems. The Pharmacological Basis of Therapeutics 2010, Macmillan Publishing Co, New York, edn 11/e. L.L. Brunton (Ed.).